Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV000644369 | SCV000766062 | likely benign | Tuberous sclerosis 2 | 2023-12-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001019156 | SCV001180479 | likely benign | Hereditary cancer-predisposing syndrome | 2018-01-24 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Gene |
RCV001550289 | SCV001770592 | likely benign | not provided | 2020-12-23 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV000644369 | SCV002041177 | benign | Tuberous sclerosis 2 | 2021-11-07 | criteria provided, single submitter | clinical testing |